Detalhe da pesquisa
1.
Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.
Clin Chem
; 66(1): 149-160, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628139
2.
Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows.
Clin Chem
; 65(9): 1132-1140, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31235535
3.
Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap).
Int J Cancer
; 143(10): 2584-2591, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30006930
4.
Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells.
Adv Exp Med Biol
; 994: 181-203, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28560675
5.
A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer.
Int J Mol Sci
; 18(9)2017 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28858218
6.
Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future?
Mol Aspects Med
; 72: 100844, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959359
7.
Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells.
Cytometry B Clin Cytom
; 98(4): 355-367, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32212383
8.
Multicenter Evaluation of Independent High-Throughput and RT-qPCR Technologies for the Development of Analytical Workflows for Circulating miRNA Analysis.
Cancers (Basel)
; 12(5)2020 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380788
9.
Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling.
Cancers (Basel)
; 12(6)2020 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32560092
10.
Circulating Tumor Cell PD-L1 Expression as Biomarker for Therapeutic Efficacy of Immune Checkpoint Inhibition in NSCLC.
Cells
; 8(8)2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31374957
11.
EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients.
Oncotarget
; 9(86): 35705-35716, 2018 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30479699